Yi Jun Lu
Corporate Officer/Principal at CANBRIDGE PHARMACEUTICALS INC.
Profile
Yi Jun Lu is currently the General Manager at CANbridge Pharmaceuticals Inc. Prior to this, he worked as the Head of Hemophilia & Rare Disease at Takeda (China) Holdings Co. Ltd.
for a brief period in 2020 and as the Head of Hematology at Shire Bioscience (Shanghai) Co., Ltd.
from 2018 to 2019.
Yi Jun Lu active positions
Companies | Position | Start |
---|---|---|
CANBRIDGE PHARMACEUTICALS INC. | Corporate Officer/Principal | 2020-11-08 |
Former positions of Yi Jun Lu
Companies | Position | End |
---|---|---|
Takeda (China) Holdings Co. Ltd. | Corporate Officer/Principal | 2020-10-31 |
Shire Bioscience (Shanghai) Co., Ltd. | Corporate Officer/Principal | 2019-03-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
Private companies | 2 |
---|---|
Takeda (China) Holdings Co. Ltd. | |
Shire Bioscience (Shanghai) Co., Ltd. |
- Stock Market
- Insiders
- Yi Jun Lu